¥29.25 ($4.36)

+0.37 (+1.28%)

SHZ · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 55 · ¥17.1B mcap · 420M float · 0.833% daily turnover

Revenue

$9.0B +9.7% ▲

5Y CAGR: +14.4%

Gross Profit

$4.1B +8.1% ▲

5Y CAGR: +11.9%

Operating Income

$915M +11.8% ▲

5Y CAGR: +7.3%

Net Income

$695M +19.8% ▲

5Y CAGR: +4.9%

EPS (Diluted)

$1.19 +21.4% ▲

5Y CAGR: +2.7%

EBITDA

$1.1B +14.9% ▲

5Y CAGR: +10.3%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$12.5B	$8.0B	$11.4B	$8.2B	$9.0B
YoY Growth	+174.0%	-35.9%	+41.2%	-27.9%	+9.7%
Cost of Revenue	$5.2B	$4.1B	$6.3B	$4.4B	$4.9B
Gross Profit	$7.3B	$3.9B	$5.0B	$3.8B	$4.1B
Gross Margin	58.4%	48.7%	44.1%	46.3%	45.6%
R&D Expenses	$411M	$298M	$488M	$322M	$348M
SG&A Expenses	$2.0B	$2.4B	$2.6B	$2.8B	$2.9B
Operating Expenses	$2.8B	$2.4B	$3.0B	$3.0B	$3.2B
Operating Income	$4.5B	$1.5B	$2.0B	$818M	$915M
Operating Margin	36.2%	18.4%	17.4%	10.0%	10.2%
Interest Expense	$5M	$31M	$53M	$64M	$58M
Income Before Tax	$4.5B	$1.5B	$1.9B	$750M	$908M
Tax Expense	$680M	$225M	$245M	$121M	$168M
Net Income	$3.8B	$1.2B	$1.7B	$580M	$695M
Net Margin	30.4%	15.4%	14.5%	7.1%	7.7%
EPS (Diluted)	$6.99	$2.08	$2.79	$0.98	$1.19
EBITDA	$4.9B	$1.3B	$2.0B	$993M	$1.1B
Shares Outstanding	597M	596M	588M	592M	584M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$2.0B	$2.9B	$2.6B	$2.7B	$2.6B	$3.1B	$2.7B	$2.8B
Cost of Revenue	$1.0B	$1.7B	$1.3B	$1.4B	$1.3B	$1.7B	$1.4B	$1.5B
Gross Profit	$1.0B	$1.2B	$1.3B	$1.3B	$1.3B	$1.4B	$1.3B	$1.3B
Gross Margin	50.4%	40.4%	48.5%	47.0%	49.6%	45.9%	48.9%	45.1%
R&D Expenses	$89M	$116M	$92M	$102M	$97M	$120M	$91M	$96M
SG&A Expenses	$714M	$888M	$798M	$868M	$861M	-$838M	$823M	$828M
Operating Expenses	$817M	$945M	$922M	$945M	$984M	$1.1B	$958M	$972M
Operating Income	$210M	$231M	$340M	$319M	$306M	$271M	$353M	$295M
Operating Margin	10.3%	8.0%	13.1%	11.8%	11.8%	8.9%	13.2%	10.5%
Interest Expense	$14M	$17M	$16M	$17M	$22M	$739K	$13M	$13M
Income Before Tax	$209M	$226M	$334M	$311M	$305M	$97M	$348M	$314M
Tax Expense	$29M	$71M	$73M	$55M	$48M	$58M	$77M	$40M
Net Income	$169M	$142M	$249M	$243M	$240M	$36M	$251M	$262M
Net Margin	8.3%	4.9%	9.5%	9.0%	9.2%	1.2%	9.4%	9.3%
EPS (Diluted)	$0.29	$0.24	$0.43	$0.42	$0.42	$0.06	$0.43	$0.45
EBITDA	$337M	$241M	$454M	$343M	$415M	$449M	$353M	$468M
Shares Outstanding	582M	587M	578M	582M	578M	582M	582M	582M

300888.SZ SHZ